A
Acerta Pharma
Clinical research on cancer and autoimmune diseases
At a glance
- Founded
- 2013
- Headquarters
- Oss, Netherlands
- Sector
- Biotech & Life Sciences
- Power Law
- Unicorn$1–10B valuation tierThoroughbred$100M+ revenue
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
Series A2 investors entered at this stage
OrbiMed- FPFrazier Healthcare Partners
Source: Dealroom Talent Intelligence.
Alumni founders
Former Acerta Pharma employees who went on to found companies, sorted by Dealroom signal score.
AZAzafarosEst. 2018
ATArtica TherapeuticsEst. 2020
Tjeerd BarfNetherlands
ATAirNexis TherapeuticsEst. 2025
Maria FardisUnited States
VEVelosBioEst. 2017
Dave JohnsonUnited StatesGlobal footprint
team presence
across markets
Patents
26 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Market sentiment
An AI-synthesised read of the highest-engagement posts about Acerta Pharma on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Acerta Pharma on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.
